product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Mouse anti Mouse CD90
catalog :
MCA02R
quantity :
0.25 mg
price :
384 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
F7D5
reactivity :
mouse
application :
flow cytometry, other
more info or order :
citations: 13
Published Application/Species/Sample/DilutionReference
  • other; mouse; loading ...; fig 5
Brown R, Xiong W, Peters J, Tekmen Clark M, Strycharska Orczyk I, REED B, et al. TRPM3 expression in mouse retina. PLoS ONE. 2015;10:e0117615 pubmed publisher
  • other; mouse; fig 5
Giera S, Deng Y, Luo R, Ackerman S, Mogha A, Monk K, et al. The adhesion G protein-coupled receptor GPR56 is a cell-autonomous regulator of oligodendrocyte development. Nat Commun. 2015;6:6121 pubmed publisher
  • other; mouse; fig 1
Bai N, Hayashi H, Aida T, Namekata K, Harada T, Mishina M, et al. Dock3 interaction with a glutamate-receptor NR2D subunit protects neurons from excitotoxicity. Mol Brain. 2013;6:22 pubmed publisher
Fernandes K, Mitchell K, Patel A, Marola O, Shrager P, Zack D, et al. Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury. Exp Eye Res. 2018;171:54-61 pubmed publisher
Welsbie D, Mitchell K, Jaskula Ranga V, Sluch V, Yang Z, Kim J, et al. Enhanced Functional Genomic Screening Identifies Novel Mediators of Dual Leucine Zipper Kinase-Dependent Injury Signaling in Neurons. Neuron. 2017;94:1142-1154.e6 pubmed publisher
Quigley H, Pitha I, Welsbie D, Nguyen C, Steinhart M, Nguyen T, et al. Losartan Treatment Protects Retinal Ganglion Cells and Alters Scleral Remodeling in Experimental Glaucoma. PLoS ONE. 2015;10:e0141137 pubmed publisher
Trakhtenberg E, Wang Y, Morkin M, Fernandez S, Mlacker G, Shechter J, et al. Regulating Set-?'s Subcellular Localization Toggles Its Function between Inhibiting and Promoting Axon Growth and Regeneration. J Neurosci. 2014;34:7361-74 pubmed publisher
Volgyi B, Pan F, Paul D, Wang J, Huberman A, Bloomfield S. Gap junctions are essential for generating the correlated spike activity of neighboring retinal ganglion cells. PLoS ONE. 2013;8:e69426 pubmed publisher
Dugas J, Emery B. Purification of oligodendrocyte precursor cells from rat cortices by immunopanning. Cold Spring Harb Protoc. 2013;2013:745-58 pubmed publisher
Winzeler A, Wang J. Purification and culture of retinal ganglion cells from rodents. Cold Spring Harb Protoc. 2013;2013:643-52 pubmed publisher
Winzeler A, Mandemakers W, Sun M, Stafford M, Phillips C, Barres B. The lipid sulfatide is a novel myelin-associated inhibitor of CNS axon outgrowth. J Neurosci. 2011;31:6481-92 pubmed publisher
Yin Y, Cui Q, Gilbert H, Yang Y, Yang Z, Berlinicke C, et al. Oncomodulin links inflammation to optic nerve regeneration. Proc Natl Acad Sci U S A. 2009;106:19587-92 pubmed publisher
Suzuki A, Kaisho T, Ohishi M, Tsukio Yamaguchi M, Tsubata T, Koni P, et al. Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination. J Exp Med. 2003;197:657-67 pubmed
image
image 1 :
Bio-Rad MCA02R image 1
Figure A. RPE conjugated rat anti mouse CD4 ( MCA2691PE ). Figure B. RPE conjugated rat anti mouse CD4 ( MCA2691PE ) and A488 conjugated mouse anti mouse CD90 ( MCA02A488 ). All experiments performed on red cell lysed murine splenocytes gated on mononuclear cells. Data acquired on the ZE5 cell analyzer.
product information
Entity Type :
Monoclonal Antibody
Entity Category :
Antibodies
ProductCode :
MCA02R
Description :
Mouse anti Mouse CD90
Specificity :
CD90
TargetSpecies :
Mouse
Host :
Mouse
Format :
Purified
Isotypes :
IgM
Applications :
F,CT
ApplicationTypes :
Flow Cytometry,Cytotoxic Assays
Clone :
F7D5
Quantity :
0.25 mg
Quantity Value :
0.25
Quantity Type :
mg
GO Accessions :
GO:0001525,GO:0007010,GO:0005100,GO:0006469,GO:0016337,GO:0030336,GO:0030425,GO:0030426,GO:0031362,GO:0034235,GO:0043547,GO:0045121,GO:0046549,GO:0048041,GO:0050771,GO:0050852,GO:0050860,GO:0050870,GO:0051281
GOTerms :
angiogenesis,cytoskeleton organization,Rho GTPase activator activity,negative regulation of protein kinase activity,cell-cell adhesion,negative regulation of cell migration,dendrite,growth cone,anchored to external side of plasma membrane,GPI anchor binding,positive regulation of GTPase activity,membrane raft,retinal cone cell development,focal adhesion assembly,negative regulation of axonogenesis,T cell receptor signaling pathway,negative regulation of T cell receptor signaling pathway,positive regulation of T cell activation,positive regulation of release of sequestered calcium ion into cytosol
Uniprot Accessions :
P01831
Gene :
Thy1
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=21838
Published Synonyms :
THY1
Entity Formats :
Purified
UNSPSC :
41116161
Concentration :
IgM concentration 1.0 mg/ml.
Product Form :
IgM fraction - liquid.
PriceGBP :
274
PriceEUR :
384
PriceUSD :
384 USD
PriceCHF :
418
PriceSEK :
4378
PriceNOK :
4371
PriceDKK :
2864
more info or order :
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.